On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
Shares in Neurocrine Biosciences took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff ...
Traders work on the trading floor at The New York Stock Exchange (NYSE) following the Federal Reserve rate announcement, in New York City, U.S., September 18, 2024. REUTERS/Andrew Kelly/File Photo ...
Treatment with the drug was associated with a statistically significant improvement on the primary endpoint of the time-weighted sum of the pain intensity difference in the first 48 hours after a ...
Get the latest Australian and world news covering breaking news and trending topics that educate, engage and entertain. Learn more about where you live, the language you speak, and how the country ...
At UN, Erdogan skips mention of Kashmir, a first since 2019 NEW YORK: Turkish President Recep Tayyip Erdogan did not mention Kashmir in his address at the UNGA this year, the first time he has ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
John Walsh Signing The Third Man: The Official … 28 Sep 2024, 2 p.m. London Megastore Kristian Nairn Signing Beyond The Throne 3 Oct 2024, 5:30 p.m. London Megastore Peter F. Hamilton Signing Exodus: ...